The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo (original) (raw)

References

  1. King, R.W., Jackson, P.K. & Kirschner, M.W. Mitosis in transition. Cell 79, 563–571 (1994).
    Article CAS PubMed Google Scholar
  2. Heichman, K.A. & Roberts, J.M. Rules to replicate by. Cell 79, 557–562 (1994).
    Article CAS PubMed Google Scholar
  3. Sherr, C.J. G1 phase progression: Cycling on cue. Cell 79, 551–555 (1994).
    Article CAS PubMed Google Scholar
  4. Nurse, P. Ordering S phase and M phase in the cell cycle. Cell 79, 547–550 (1994).
    Article CAS PubMed Google Scholar
  5. Hunter, T. & Pines, J. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).
    Article CAS PubMed Google Scholar
  6. Peter, M. & Herskowitz, I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79, 181–184 (1994).
    Article CAS PubMed Google Scholar
  7. Chang, F. & Herskowitz, I. Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2. Cell 63, 999–1011 (1990).
    Article CAS PubMed Google Scholar
  8. Zhang, H., Hannon, G.J. & Beach, D. & Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750–1758 (1994).
    Article CAS PubMed Google Scholar
  9. Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993).
    Article CAS PubMed Google Scholar
  10. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).
    Article CAS PubMed Google Scholar
  11. Polyak, K. et al. Cloning of p27Kip1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 (1994).
    Article CAS PubMed Google Scholar
  12. Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67–74 (1994).
    Article CAS PubMed Google Scholar
  13. Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
    Article CAS PubMed Google Scholar
  14. Hannon, G.J. & Beach, D. p15INK4B is a potential effector of TGF—induced cell cycle arrest. Nature 371, 257–261 (1994).
    Article CAS PubMed Google Scholar
  15. El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
    Article CAS PubMed Google Scholar
  16. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M. & Smith, J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Expl. Cell Res. 211, 90–98 (1994).
    Article CAS Google Scholar
  17. Gu, Y., Turck, C.W. & Morgan, D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707–710 (1993).
    Article CAS PubMed Google Scholar
  18. Li, Y., Jenkins, C.W., Nichols, M.A. & Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9, 2261–2268 (1994).
    CAS PubMed Google Scholar
  19. El-Deiry, W.S. et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169–1174 (1994).
    CAS PubMed Google Scholar
  20. Di Leonardo, A., Linke, S.P., Clarkin, K. & Wahl, G.M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cipl in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994).
    Article CAS PubMed Google Scholar
  21. Dulic, V. et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013–1023 (1994).
    Article CAS PubMed Google Scholar
  22. Li, R., Waga, S., Hannon, G.J., Beach, D. & Stillman, B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371, 534–537 (1994).
    Article CAS PubMed Google Scholar
  23. Li, C.Y., Suardet, L. & Little, J.B. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J. biol. Chem. 270, 4971–4974 (1995).
    Article CAS PubMed Google Scholar
  24. Symonds, H. et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703–711 (1994).
    Article CAS PubMed Google Scholar
  25. Chen, P.L., Scully, P., Shew, J.Y., Wang, J.Y. & Lee, W.H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193–1198 (1989).
    Article CAS PubMed Google Scholar
  26. Kato, J.T., Matsushiml, H., Hiebert, S.W., Ewen, M.E. & Sherr, C.J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7, 331–342 (1993).
    Article CAS PubMed Google Scholar
  27. Hu, Q.J., Lees, J.A., Buchleovich, K.J. & Harlow, E. The retinoblastoma protein physically associates with the human cdc2 kinase. Molec. cell. Biol. 12, 971–980 (1992).
    Article CAS PubMed PubMed Central Google Scholar
  28. Lin, B.T.-Y., Gruenwald, S., Morla, A.O., Lee, W.-H. & Wang, J. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10, 857–866 (1991).
    Article CAS PubMed PubMed Central Google Scholar
  29. Ewen, M.E. et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487–497 (1993).
    Article CAS PubMed Google Scholar
  30. Riley, D.J., Lee, E.Y. & Lee, W.H. The retinoblastoma protein, more than a tumor suppressor. Annu. Rev. Cell Biol. 10, 1–29 (1994).
    Article CAS PubMed Google Scholar
  31. Chellappen, S.P., Heibert, S., Mudryi, M., Horowitz, J.M. & Nevins, J.R. The E2F transcription factor is a cellular target for the Rb protein. Cell 65, 1053–1061 (1991).
    Article Google Scholar
  32. Dynlacht, B.D., Flores, O., Lees, J.A. & Harlow, E. Differential regulation of E2F transactivation by cyclin/CDK2 complexes. Genes Dev. 8, 1722–1786 (1994).
    Article Google Scholar
  33. Schneider, K.R., Smith, R.L. & O'Shea, E.K. Phosphate-regulated inactivation of the kinase PH080-PH085 by the CDK inhibitor PH081. Science 266, 122–126 (1994).
    Article CAS PubMed Google Scholar
  34. Kaffman, A., Herskowitz, I., Tjian, R. & O'Shea, E.K. Phosphorylation of the transcription factor PH04 by a cyclin-CDK complex, PH080-PH085. Science 263, 1153–1156 (1994).
    Article CAS PubMed Google Scholar
  35. Christman, J.K., Mendelsohn, N., Herzog, D. & Schneiderman, N. Effect of 5-azacytidine on differentation and DNA methylation in human promyelocytic leukemia cells (HL-60). Cancer Res. 43, 763–769 (1983).
    CAS PubMed Google Scholar
  36. Samid, D., Shack, S. & Sherman, L.T. Phenylacetate: A novel nontoxic inducer of tumor cell differentation. Cancer Res. 52, 1988–1992 (1992).
    CAS PubMed Google Scholar
  37. Pierce, G.B. & Speers, W.C. Tumor as caricatures of the process of tissue renewal: Prospects for therapy by directing differentation. Cancer Res. 48, 1996–2006 (1988).
    CAS PubMed Google Scholar
  38. Leftwich, J.A. & Hall, R.E. Enhancement of phorbol ester-induced HL-60-mediated cytotoxicity by retinoic acid, dimethyl sulfoxide and 5-azacytidine. Cancer Res. 46, 3789–3792 (1986).
    CAS PubMed Google Scholar
  39. Chen, S.H. et al. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. natn. Acad. Sci. U.S.A. 92, 2577–2581 (1995).
    Article CAS Google Scholar
  40. Davidson, B.L., Allen, E.D., Kozarsky, K.F., Wilson, J.M. & Roessler, B.J. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219–223 (1993).
    Article CAS PubMed Google Scholar
  41. Ohno, T. et al. Gene therapy for vascular smooth muscle cell proliferation following arterial injury. Science 265, 781–784 (1994).
    Article CAS PubMed Google Scholar
  42. Mosman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. immunol. Methods 65, 55–63 (1983).
    Article Google Scholar
  43. Ito, S., Wakamatsu, K. & Ozeki, H. Spectrophotometric assay of eumelanins in tissue samples. Anal. Biochem. 215, 273–277 (1993).
    Article CAS PubMed Google Scholar
  44. Gorczyca, W. et al. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7, 659–670 (1993).
    CAS PubMed Google Scholar

Download references